Programs: Maryland Medical Assistance Program (MA)



Download 3.34 Mb.
Page9/34
Date31.01.2017
Size3.34 Mb.
#14652
1   ...   5   6   7   8   9   10   11   12   ...   34
N

d03180

74

5/5/2000

ritonavir

Norvir

1

Protease Inhibitor

N

d03984

28

7/14/2000

rosuvastatin

Crestor

0

Antilipemic Agent

N

d04851

149

4/27/2006

saguinavir

Fortovase, SQV

1

Protease Inhibitor

N

d03860

37

7/14/2000

sertraline

Zoloft

0

Antidepressant

N

d00880

72

5/5/2000

spironolactone

(generic only)

0

Antihypertensive

N

d00373

128

2/28/2006

stavudine

Zerit, d4T

1

Anti-retroviral NRTI

N

d03773

24

11/1/1994

sulfadiazine

Sulfadiazine

0

Toxoplasmosis

N

d00118

38

7/14/2000

tenofovir disoproxil fumarate

Viread

1

Anti-retroviral NRTI

N

d04774

85

1/1/2002

testosterone transdermal

Androderm, Androgel, Testim

0

Wasting

N

d00558

41

7/14/2000

thalidomide

Thalomid

0

Wasting

N

d04331

57

2/1/1999

tipranavir

Aptivus

1

Protease Inhibitor

N

d05538

119

9/27/2005

TMP-SMX

Bactrim, Septra, Septra DS

0

PCP Prophylaxis

N

d00124

18

5/1/1992

trazadone HCL

Desyrel, Desyrel Dividose

0

Antidepressant

N

d00395

80




triamterene

(generic only)

0

Antihypertensive

N

d00396

125

2/28/2006

trimethoprim

Proloprim, Trimpex

0

Antibiotics

N

d00123

100

12/1/2003

triphasic ethestradiol-norgestimate

Tri-Sprintec 28

0

Contraceptive

N

d03781

140

2/28/2006

valacyclovir

Valtrex

0

Antiviral

N

d03838

45

7/14/2000

valganciclovir hydrochloride

Valcyte

0

Antiviral

N

d04755

84




venlafaxine HCL

Effexor XR

0

Antidepressant

N

d03181

116

8/1/2004

verapamil

(generic only)

0

Antihypertensive

N

d00048

133

2/28/2006

zalcitabine

Hivid, ddC

1

Anti-retroviral NRTI

N

d00127

19

1/1/1993

zidovudine

Retrovir, AZT

1

Anti-retroviral NRTI

N

d00034

01

1/1/1992

zidovudine-lamivudine

Combivir

2

Anti-retroviral NRTI

N

d04219

33

7/14/2000

Carbamazepine

Tegretol, & XR




anticonvulsant N

N

d00058

154

10/26/06

* Y Indicates Prior Authorization Required


NOTE: Peginterferon alfa (including 2b and 2a) and ribavirin covered in combination, and only for treatment of HCV infection in HIV co-infected clients.
The following is a list of covered injectables:


Covered Injectable Products

HSN 006071

Ciprofloxacin (Cipro i.v.)

HSN 006072

Ciprofloxacin (Cipro i.v.)

HSN 007802

Fluconazole (Diflucan)

HSN 009792

Fluconazole (Diflucan)

HSN 004869

Fluconazole (Diflucan)

HSN 004182

Acyclovir (Zovirax)

HSN 010893

Ampho B C-S (Amphotec)

HSN 004128

Amphotericin-B (Fungisone)

HSN 010219

Amphotericin-B Lipid Complex (Abelcet)

HSN 012800

Amphotericin-B Liposome (Ambisome)

HSN 006334

Azithromycin (Zithromax)

HSN 011506

Cidofovir (Vistide)

HSN 004045

Clindamycin (Cleocin)

HSN 004704

Clindamycin (Cleocin)

HSN 010804

Daunorubicin Citrate Liposomal (DaunoXorne)

HSN 004013

Doxycyline (Vibramycin)

HSN 025044

Enfuvirtide (Fuzeon)

HSN 004553

Epoetin Alpha (Epogen, Procrit)

HSN 006070

Filgrastim (Neupogen)

HSN 001624

Fluphenazine (Prolixin, generics)

HSN 001626

Fluphenazine (Prolixin, generics)

HSN 013221

Foscarnet (Foscavir)

HSN 001660

Haloperidol (Haldol)

HSN 001661

Haloperidol (Haldol)

HSN 001608

Hydroxizine (Atarax, Vistaril)

HSN 001063

Leucovorin (Wellcovorin, generics)

HSN 004157

Metronidazole (Flagyl)

HSN 001413

Nandrolone (Nadrolone)

HSN 002826

Octreotide (Sandostatin)

HSN 024035

Peginterferon alfa 2a (Pegasys)

HSN 021367

Peginterferon alfa 2b (Peg-Intron)

HSN 009599

Pentamidine (Pentam, NebuPent

HSN 001628

Prochloperazine (Compazine)

HSN 004040

Rifampin (Rifadin, Rimactane)

HSN 001400

Testosterone injection (Depo-Testosterone)

HSN 001401

Testosterone injection (Delatestryl)

Maintenance Drug List

The MADAP maintenance drug list = antiretroviral therapies (NNRTIs, NRTIs, PIs, Fusion Inhibitors).
Prior Authorization

There are three places providers can obtain a prior authorization for the MADAP program: ACS, MADAP and SmartPA. Below will outline which entity gives the Prior Authorization for which category of drug.


PA Drug List

Drug

Performed by

HSN 025044

Enfuvirtie (Fuzeon)

MADAP

HSN 004553

Epoetin Alpha (Epogen, Procrit)

SmartPA

HSN 006070

Filgrastim (Neupogen)

SmartPA

HSN 001412

Oxandrolone (Oxandrin)

SmartPA

HSN 024035

Peginterferon alfa 2a (Pegasys)

MADAP

HSN 021367

Peginterferon alfa 2b (Peg-Intron)

MADAP

HSN 004184

Ribavirin (Rebetol, Copegus)

MADAP

HSN 034927

Maraviroc (Selzentry)

MADAP

The ACS Technical Call Center will handle the following prior authorization requests for MADAP:

EarlyRefill

Quantity


Price per claim limit ≥$2500.00
The ACS PA Call Center will handle the following prior authorization requests for MADAP:

Epoetin Alpha (Epogen, Procrit)

Filgrastim (Neupogen)

Oxandrolone (Oxandrin)


The MADAP staff will handle all other prior authorization requests.
SmartPA
SmartPA is a rules engine driven program that will search existing claim and medical history to evaluate whether or not the recipient has met the set criteria to receive the drug being billed. If the recipient meets criteria then the system generates a Prior Authorization and the claim is paid. If the recipient does not meet criteria, the claim is denied with a SmartPA specific edit advising which criteria was not met.
The following categories are submitted to SmartPA for evaluation:

Epoetin Alpha (Epogen, Procrit)

Filgrastim (Neupogen)

Oxandrolone (Oxandrin)


Copay Only Claim Billing Guidelines
MADAP will allow providers to bill for a copay only claim. In order for the claim to be processed correctly, the following guidelines must be followed.

The system will require claims for COB copay only billing to adhere to the following NCPDP parameters:

NO COB SEGMENT SUBMITTED

OCC = 8


Other Amount Claimed Qualifier = 99

Other Amount Claimed = Amount of copay

Gross Amount Due = Equal Other Amount Claimed/Amount of copay

Other Amount Claimed Submitted must be the entire patient copay as charged by the pharmacy


SECTION X

MARYLAND KIDNEY DISEASE PROGRAM (KDP) SPECIFICS


This section will outline program specific information that is not covered in the beginning of this manual.
Generic Mandatory and Dispense as Written Code Usage
KDP has a generic mandatory program in place that must be followed. When providers submit a claim for a drug that has a generic equivalent and there is no active PA on file or appropriate DAW code, the claim will deny with an NCPDP Reject code ‘22’ – M/I DAW Code.
KDP accepts the following DAW codes:
ACS will ensure that the only valid DAW codes will be 0, 1, 5 and 6:

0 - default, no product selection

1 - Physician request

5 - Brand used as generic

6 – Client Override
KDP allows the use of DAW 6 for medications determined by KDP as follows (pay at EAC):

Duragesic NDCs: 50458003305, 50458003405, 50458003505, 50458003605, 50458003705

Rebetol NDCs: 00085119403, 00085132704, 00085135105, 00085138507

Flonase NDCs: 00173045301


LTC

The KDP system has no LTC recipients and will reject claims submitted with LTC identifiers (NCPDP field 307-C7, Patient Location = 3 – Nursing Home or 4-Long Term/Extended Care) with NCPDP edit 70 and message text: “LTC Claims Not Allowed for Reimbursement”.


Minimum / Maximum Quantities

The KDP program enforces the following Minimum / Maximum quantity limits:

A maximum quantity limit of 350 for the following Immunosuppressive Oral tablets/capsules will be enforced.

Azathioprine

Cyclosporine

Mycophenolate Mofetil (Cellcept)

Sirolimus (Rapamume)

Tacrolimus (Prograf)

HSN = 004523, 004524, 010086, 010012, 020519, 008974; and Route = Oral

There is a max quantity limit of 350 for Immunosuppressants, Oral tablets/capsules.

The max quantity limit for Oxycontin (GSN = 024505, 024506, 025702, 024504, 045129) is 120. Note: This is a per fill quantity limit, not an accumulation limit.
MINIMUM QUANTITY

There is a minimum quantity limit of 100 tablets for Ferrous sulfate 325mg tablets (GSN = 001645, 001646, 017378).

A minimum quantity limit of 480 ml for Ferrous sulfate elixir (220mg/5ml), GSN = 001639) will be applied.

KDP will enforce a minimum quantity limit of 60 tablets for non-legend chewable tablets of any ferrous salt when combined with vitamin C, multivitamins, multivitamins and minerals, or other minerals in the formulation (HIC3 = C3B; and Dosage form = TC).


Date of Rx Written and Date of Service

The system will enforce the following rules regarding the amount of time allowed between Date RX Written and Date of Service:

No greater than 10 days.

Claims greater than this 10 day limit will deny for NCPDP Error Code M4 (Prescription Number/Time Limit Exceeded).

Edit only applies to original prescriptions.

UNIT DOSE

The system will deny claims for unit dose medications with the exception of drugs listed below with error 70 (drug not covered) and message text: “Unit Dose Package Size”.

Unit Dose Drugs Exceptions for Retail Claims (all other U/D will deny with NCPDP 70 – NDC not covered)/ “Unit Dose Package Size”

HSN = 000739; and UD

Ferrous Sulfate (single ingredient products only)




GSN = 040910, 040911, 047126; and UD

Micardis 20mg, 40mg & 80mg




GSN = 011964, 011963, 023881, 023882; and UD

Cyclosporine 25mg & 100mg caps

Includes Gengraf

GSN = 031055, 031056; and UD

Pepcid RPD




GSN = 049296, 040887; and UD

Prevacid Liquid




GSN = 009326, 009327; and UD

Vancocin HCL




GSN = 018370; and UD

Bactroban Nasal



Pricing


ACS will ensure the claims reimburse at the following pricing:

Legend Drugs, Schedule V Cough Preps, Enteric Coated Aspirin, Oral Ferrous Sulfate Prods

Payment is lesser of:

U/C -or- Allowable Cost + Dispensing Fee

Allowable Cost is lesser of:

1. IDC,


2. EAC (lesser of): WAC+8%· Direct+8%· Distributors + 8%· AWP - 12%,

3. FUL
Chewable Ferrous Sulfate with Multivitamins

Payment is lesser of:

U/C -or- Allowable Cost + 50% -or- Allowable Cost + Dispensing Fee

Allowable Cost is lesser of:

1. IDC


2. EAC (lesser of): WAC+8% -or- Direct+8% -or- Distributors + 8% -or- AWP - 12%

3. FUL


DAW 1 and 6 Claims

Payment is lesser of:

U/C -or- Allowable Cost + Dispensing Fee

Allowable Cost:

EAC (lesser of): · WAC+8% -or- Direct+8% -or- Distributors + 8% -or- AWP – 12%

Other OTC Drugs (Insulin and Nutritional Supplements)

Payment is lesser of:

U/C -or- Allowable Cost + 50% -or- Allowable Cost + Dispensing Fee

Allowable Cost: AWP
Medical Supplies and Durable Medical Equip (Needles and Syringes)

Payment is lesser of:

U/C -or- Allowable Cost + Dispensing Fee

Allowable Cost: AWP

ACS will ensure that KDP claims do not have copays.

ACS will ensure that claims will reimburse with the following dispensing fee:

Dispensing Fee

Brand Products = $2.69

Generic Products = $3.69

Partial fills – ½ + ½ dispensing fee.

COPAY

KDP recipients do not have a copay.



PRIOR AUTHORIZATIONS

The ACS Technical Call Center will handle the following prior authorization requests for KDP:

Early Refill

Quantity


Price per claim limit ≥ $2500.00

The KDP staff will handle the following prior authorization requests:



Download 3.34 Mb.

Share with your friends:
1   ...   5   6   7   8   9   10   11   12   ...   34




The database is protected by copyright ©ininet.org 2024
send message

    Main page